Hologic, Inc. (HOLX)
USD 58.46
(-4.59%)
USD 58.46
(-4.59%)
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2024 | 1.29 Billion USD | 16.71% |
| 2023 | 1.11 Billion USD | -42.81% |
| 2022 | 2.11 Billion USD | -27.07% |
| 2021 | 2.86 Billion USD | 90.6% |
| 2020 | 1.49 Billion USD | 153.41% |
| 2019 | 346.1 Million USD | -40.38% |
| 2018 | 210.4 Million USD | 5.53% |
| 2017 | 1.83 Billion USD | -9.71% |
| 2016 | 1.03 Billion USD | 8.96% |
| 2015 | 874.1 Million USD | 115.85% |
| 2014 | 791.9 Million USD | 12.49% |
| 2013 | -395.87 Million USD | 21.23% |
| 2012 | 424.4 Million USD | -33.13% |
| 2011 | 646.96 Million USD | 116.5% |
| 2010 | 366.88 Million USD | -39.84% |
| 2009 | -1.74 Billion USD | -66.46% |
| 2008 | -21.27 Million USD | 527.5% |
| 2007 | 178.91 Million USD | 76.83% |
| 2006 | 70.55 Million USD | 151.66% |
| 2005 | 40.2 Million USD | 99.28% |
| 2004 | 20.17 Million USD | 93.43% |
| 2003 | 3.02 Million USD | -24.27% |
| 2002 | 11.7 Million USD | 295.78% |
| 2001 | -8.55 Million USD | 60.28% |
| 2000 | -22.93 Million USD | -216.29% |
| 1999 | -6.1 Million USD | -175.68% |
| 1998 | 12.7 Million USD | -60.0% |
| 1997 | 23.7 Million USD | 128.4% |
| 1996 | 18.3 Million USD | 8.0% |
| 1995 | 5.3 Million USD | 66.67% |
| 1994 | 4.7 Million USD | 336.84% |
| 1993 | -1.6 Million USD | -337.5% |
| 1992 | 1.6 Million USD | 366.67% |
| 1991 | 500 Thousand USD | -85.29% |
| 1990 | 3.4 Million USD | 88.89% |
| 1989 | 1.8 Million USD | 0.0% |
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2024 Q4 | 230.1 Million USD | -4.87% |
| 2024 Q2 | 317 Million USD | 3.86% |
| 2024 Q3 | 336.2 Million USD | 8.63% |
| 2024 Q1 | 198.2 Million USD | 22.67% |
| 2023 Q2 | 376.7 Million USD | 6.35% |
| 2023 Q4 | 305.5 Million USD | 82.5% |
| 2023 Q3 | 167.4 Million USD | -55.56% |
| 2023 FY | - USD | -42.81% |
| 2023 Q1 | 354.2 Million USD | 16.74% |
| 2022 Q4 | 303.4 Million USD | -12.29% |
| 2022 Q3 | 345.9 Million USD | -50.79% |
| 2022 Q1 | 752.4 Million USD | 66.87% |
| 2022 FY | - USD | -27.07% |
| 2022 Q2 | 702.9 Million USD | -6.58% |
| 2021 FY | - USD | 90.6% |
| 2021 Q1 | 984.6 Million USD | 48.55% |
| 2021 Q2 | 883.9 Million USD | -10.23% |
| 2021 Q3 | 463.8 Million USD | -47.53% |
| 2021 Q4 | 450.9 Million USD | -2.78% |
| 2020 Q4 | 662.8 Million USD | 128.24% |
| 2020 Q3 | 290.4 Million USD | 17.67% |
| 2020 Q2 | 246.8 Million USD | 7.35% |
| 2020 FY | - USD | 153.41% |
| 2020 Q1 | 229.9 Million USD | 131.52% |
| 2019 FY | - USD | -40.38% |
| 2019 Q1 | 261.7 Million USD | 112.42% |
| 2019 Q2 | -130.5 Million USD | -149.87% |
| 2019 Q3 | 265.4 Million USD | 303.37% |
| 2019 Q4 | 99.3 Million USD | -62.58% |
| 2018 Q3 | 266.1 Million USD | 8.26% |
| 2018 Q2 | 245.8 Million USD | -6.47% |
| 2018 Q1 | 262.8 Million USD | 107.26% |
| 2018 FY | - USD | 5.53% |
| 2018 Q4 | 123.2 Million USD | -53.7% |
| 2017 Q2 | 202.1 Million USD | -26.51% |
| 2017 Q3 | 240.5 Million USD | 19.0% |
| 2017 Q4 | 126.8 Million USD | -47.28% |
| 2017 Q1 | 275 Million USD | 60.26% |
| 2017 FY | - USD | -9.71% |
| 2016 Q4 | 171.6 Million USD | -34.65% |
| 2016 Q1 | 272.1 Million USD | 11.84% |
| 2016 FY | - USD | 8.96% |
| 2016 Q3 | 262.6 Million USD | 3.67% |
| 2016 Q2 | 253.3 Million USD | -6.91% |
| 2015 Q3 | 249.7 Million USD | 4.56% |
| 2015 Q2 | 238.8 Million USD | 2.36% |
| 2015 Q1 | 233.3 Million USD | 66.52% |
| 2015 FY | - USD | 115.85% |
| 2015 Q4 | 243.3 Million USD | -2.56% |
| 2014 Q3 | 111.4 Million USD | 32.81% |
| 2014 Q4 | 140.1 Million USD | 25.76% |
| 2014 FY | - USD | 12.49% |
| 2014 Q1 | 107.37 Million USD | -52.5% |
| 2014 Q2 | 83.88 Million USD | -21.88% |
| 2013 FY | - USD | 21.23% |
| 2013 Q4 | 226.05 Million USD | 92.1% |
| 2013 Q3 | 117.67 Million USD | 53.1% |
| 2013 Q2 | 76.86 Million USD | -7.2% |
| 2013 Q1 | 82.82 Million USD | 62.56% |
| 2012 FY | - USD | -33.13% |
| 2012 Q1 | 110.07 Million USD | -27.85% |
| 2012 Q3 | 98.48 Million USD | 30.19% |
| 2012 Q4 | 50.95 Million USD | -48.26% |
| 2012 Q2 | 75.64 Million USD | -31.27% |
| 2011 Q3 | 91.45 Million USD | -46.33% |
| 2011 Q1 | 86.71 Million USD | 190.68% |
| 2011 Q2 | 170.4 Million USD | 96.5% |
| 2011 FY | - USD | 116.5% |
| 2011 Q4 | 152.55 Million USD | 66.81% |
| 2010 Q2 | 76.08 Million USD | -11.75% |
| 2010 FY | - USD | -39.84% |
| 2010 Q3 | 92.66 Million USD | 21.79% |
| 2010 Q4 | 29.83 Million USD | -67.81% |
| 2010 Q1 | 86.22 Million USD | -41.47% |
| 2009 Q2 | 141.56 Million USD | -13.14% |
| 2009 Q1 | 162.98 Million USD | -53.39% |
| 2009 Q3 | 91.97 Million USD | -35.03% |
| 2009 Q4 | 147.3 Million USD | 60.16% |
| 2009 FY | - USD | -66.46% |
| 2008 Q2 | 151.57 Million USD | -66.81% |
| 2008 Q4 | 349.71 Million USD | 112.32% |
| 2008 Q3 | 164.71 Million USD | 8.67% |
| 2008 Q1 | 456.69 Million USD | 739.69% |
| 2008 FY | - USD | 527.5% |
| 2007 FY | - USD | 76.83% |
| 2007 Q1 | 34.74 Million USD | -1.05% |
| 2007 Q2 | 42.22 Million USD | 21.51% |
| 2007 Q3 | 47.55 Million USD | 12.62% |
| 2007 Q4 | 54.38 Million USD | 14.38% |
| 2006 Q1 | 18.78 Million USD | 40.79% |
| 2006 Q4 | 35.11 Million USD | 61.1% |
| 2006 Q3 | 21.79 Million USD | 14.28% |
| 2006 Q2 | 19.07 Million USD | 1.54% |
| 2006 FY | - USD | 151.66% |
| 2005 Q2 | 8.99 Million USD | 38.57% |
| 2005 Q3 | 11.37 Million USD | 26.43% |
| 2005 Q4 | 13.34 Million USD | 17.31% |
| 2005 FY | - USD | 99.28% |
| 2005 Q1 | 6.49 Million USD | -9.54% |
| 2004 Q3 | 5.28 Million USD | 12.68% |
| 2004 Q2 | 4.69 Million USD | 55.28% |
| 2004 Q4 | 7.17 Million USD | 35.77% |
| 2004 Q1 | 3.02 Million USD | -33.06% |
| 2004 FY | - USD | 93.43% |
| 2003 FY | - USD | -24.27% |
| 2003 Q4 | 4.51 Million USD | 53.61% |
| 2003 Q2 | 343 Thousand USD | 289.97% |
| 2003 Q3 | 1.09 Million USD | 23.91% |
| 2003 Q1 | 646 Thousand USD | 1.84% |
| 2002 Q4 | 2.89 Million USD | -83.92% |
| 2002 Q2 | 3.03 Million USD | -18.47% |
| 2002 Q1 | 2.75 Million USD | 276.04% |
| 2002 FY | - USD | 295.78% |
| 2002 Q3 | 3.02 Million USD | 5.24% |
| 2001 Q3 | 1.97 Million USD | 407.45% |
| 2001 Q4 | -1.19 Million USD | -168.45% |
| 2001 FY | - USD | 60.28% |
| 2001 Q2 | -2.2 Million USD | 75.37% |
| 2001 Q1 | -4.66 Million USD | 23.8% |
| 2000 Q1 | -4.6 Million USD | 8.33% |
| 2000 FY | - USD | -216.29% |
| 2000 Q2 | -3.23 Million USD | 27.57% |
| 2000 Q3 | -3.84 Million USD | -20.46% |
| 2000 Q4 | -11.36 Million USD | -62.1% |
| 1999 Q2 | -1.5 Million USD | -580.0% |
| 1999 FY | - USD | -175.68% |
| 1999 Q1 | 2.3 Million USD | -109.62% |
| 1999 Q4 | -4.7 Million USD | -140.0% |
| 1999 Q3 | -2.19 Million USD | 41.18% |
| 1998 FY | - USD | -60.0% |
| 1998 Q2 | 3.3 Million USD | 58.33% |
| 1998 Q3 | 6.5 Million USD | 36.84% |
| 1998 Q4 | 3.8 Million USD | 100.0% |
| 1998 Q1 | 1.4 Million USD | -61.29% |
| 1997 Q2 | 6.4 Million USD | -3.85% |
| 1997 Q4 | 4.7 Million USD | -38.0% |
| 1997 Q3 | 6.4 Million USD | 0.0% |
| 1997 FY | - USD | 128.4% |
| 1997 Q1 | 6.2 Million USD | 236.84% |
| 1996 Q2 | 3.9 Million USD | -8.11% |
| 1996 Q4 | 600 Thousand USD | -171.7% |
| 1996 Q3 | 5.9 Million USD | 55.88% |
| 1996 Q1 | 2.8 Million USD | 2.78% |
| 1996 FY | - USD | 8.0% |
| 1995 Q2 | 300 Thousand USD | -90.91% |
| 1995 Q3 | 1.4 Million USD | 2000.0% |
| 1995 Q1 | 1.1 Million USD | 22.22% |
| 1995 Q4 | 2.2 Million USD | 71.43% |
| 1995 FY | - USD | 66.67% |
| 1994 Q2 | 1.5 Million USD | 180.0% |
| 1994 Q1 | 600 Thousand USD | 133.33% |
| 1994 FY | - USD | 336.84% |
| 1994 Q4 | 900 Thousand USD | -43.75% |
| 1994 Q3 | 1.7 Million USD | 14.29% |
| 1993 Q2 | -200 Thousand USD | -105.56% |
| 1993 FY | - USD | -337.5% |
| 1993 Q4 | -1 Million USD | -1400.0% |
| 1993 Q1 | 5.4 Million USD | 1900.0% |
| 1993 Q3 | -100 Thousand USD | 66.67% |
| 1992 FY | - USD | 366.67% |
| 1992 Q4 | -100 Thousand USD | -175.0% |
| 1992 Q1 | 300 Thousand USD | 100.81% |
| 1992 Q2 | 500 Thousand USD | 400.0% |
| 1992 Q3 | 700 Thousand USD | -20.0% |
| 1991 Q1 | 3.9 Million USD | 133.05% |
| 1991 Q2 | 4.2 Million USD | 7.69% |
| 1991 Q3 | 4.5 Million USD | 7.14% |
| 1991 Q4 | -12.4 Million USD | -375.56% |
| 1991 FY | - USD | -110.71% |
| 1990 FY | - USD | 64.71% |
| 1990 Q1 | 3.9 Million USD | 161.9% |
| 1990 Q4 | -11.8 Million USD | -296.67% |
| 1990 Q3 | 6 Million USD | 757.14% |
| 1990 Q2 | 700 Thousand USD | -82.05% |
| 1989 Q2 | 2.6 Million USD | 18.18% |
| 1989 Q3 | 3.2 Million USD | 23.08% |
| 1989 Q4 | -6.3 Million USD | -296.88% |
| 1989 FY | - USD | 0.0% |
| 1989 Q1 | 2.2 Million USD | 0.0% |
| Name | EBITDA | EBITDA Difference |
|---|---|---|
| Akoya Biosciences, Inc. | -45.63 Million USD | 2940.55% |
| AngioDynamics, Inc. | -14.29 Million USD | 9169.409% |
| AtriCure, Inc. | -8.1 Million USD | 16084.708% |
| Avinger, Inc. | -16.34 Million USD | 8029.769% |
| Azenta, Inc. | 55.15 Million USD | -2250.275% |
| BioLife Solutions, Inc. | -45.23 Million USD | 2965.29% |
| The Cooper Companies, Inc. | 882.8 Million USD | -46.828% |
| Daxor Corporation | 329.74 Thousand USD | -392997.592% |
| Ekso Bionics Holdings, Inc. | -13.19 Million USD | 9921.185% |
| Femasys Inc. | -13.16 Million USD | 9942.505% |
| GlucoTrack, Inc. | -7.09 Million USD | 18379.509% |
| Harvard Bioscience, Inc. | 9.49 Million USD | -13554.272% |
| ICU Medical, Inc. | 307.69 Million USD | -321.263% |
| Intuitive Surgical, Inc. | 2.39 Billion USD | 45.859% |
| KORU Medical Systems, Inc. | -9.39 Million USD | 13889.965% |
| LeMaitre Vascular, Inc. | 48.99 Million USD | -2545.846% |
| Innovative Eyewear, Inc. | -6.57 Million USD | 19813.664% |
| Innovative Eyewear, Inc. | -6.57 Million USD | 19813.664% |
| Masimo Corporation | 236.7 Million USD | -447.613% |
| Microbot Medical Inc. | -10.63 Million USD | 12289.204% |
| Meihua International Medical Technologies Co., Ltd. | 15.77 Million USD | -8119.117% |
| Merit Medical Systems, Inc. | 231.44 Million USD | -460.054% |
| Nephros, Inc. | -1.37 Million USD | 94095.649% |
| NovoCure Limited | -175.86 Million USD | 837.043% |
| NEXGEL, Inc. | -2.73 Million USD | 47579.853% |
| NEXGEL, Inc. | -2.73 Million USD | 47579.853% |
| Singular Genomics Systems, Inc. | -86.49 Million USD | 1598.566% |
| OraSure Technologies, Inc. | 76.15 Million USD | -1601.988% |
| Pro-Dex, Inc. | 8.33 Million USD | -15455.022% |
| Pulse Biosciences, Inc. | -42.36 Million USD | 3159.457% |
| Predictive Oncology Inc. | -13.18 Million USD | 9933.097% |
| Precision Optics Corporation, Inc. | -2.51 Million USD | 51701.325% |
| QuidelOrtho Corporation | 545.6 Million USD | -137.573% |
| Repligen Corporation | 124.29 Million USD | -942.867% |
| Sanara MedTech Inc. | -289.09 Thousand USD | 448461.623% |
| STAAR Surgical Company | 33.22 Million USD | -3801.749% |
| Sharps Technology, Inc. | -8.98 Million USD | 14533.67% |
| Utah Medical Products, Inc. | 24.8 Million USD | -5125.559% |
| DENTSPLY SIRONA Inc. | 232 Million USD | -458.707% |
| Jin Medical International Ltd. | 3.44 Million USD | -37548.658% |